Lv11
50 积分 2025-10-20 加入
Tarlatamab in Small-Cell Lung Cancer after Platinum-Based Chemotherapy
1小时前
待确认
Durvalumab after Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer
1个月前
已完结
Immune heterogeneity in small-cell lung cancer and vulnerability to immune checkpoint blockade
1个月前
已完结
Long-term overall survival with dual CTLA-4 and PD-L1 or PD-1 blockade and biomarker-based subgroup analyses in patients with advanced non-small-cell lung cancer: a systematic review and reconstructed individual patient data meta-analysis
1个月前
已完结
Bortezomib plus rituximab alone in patients with relapsed, rituximab-naive or rituximab-sensitive, follicular lymphoma: a randomised phase 3 Trial
1个月前
已完结
The current and emerging immunotherapy paradigm in small-cell lung cancer
2个月前
已完结
Immune Checkpoint Inhibitors Rechallenge in Non-Small Cell Lung Cancer: Current Evidence and Future Directions
2个月前
已完结
皖公网安备34019202002308
